glenn_dourado
1999
Glenn Dourado, MBA, has been appointed Vice President, Business Development at Poseida Therapeutics, Inc., a San Diego-based company that translates best-in-class gene-editing technologies into lifesaving therapeutics. Glenn joined the company from Ligand Pharmaceuticals, after having worked at Sanford Burnham Medical Research Institute, The Dow Chemical Company, and Johnson & Johnson, among others.Â